why choose us

First received: October 11, 2023

Clinical Trial: Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase I, Multicenter, Open-label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacodynamics, and Pharmacokinetics of Intravenous QN-302 in Patients With Advanced or Metastatic

Brief Summary: Goal: learn about QN-302 in patients with solid tumors (metastatic, or advanced cancer).Main questions:What does the study drug do to human body (Pharmacodynamics [='PD'])What does the body do to study drug (how processed in body (Pharmacokinetics [='PK']) - SafetyStudy drug by intravenous infusion ('IV') once weekly for 3 weeks every 4-week 'cycle.'Study treatment continues as long as patient and their study doctor agree that study treatment is in the best interest of the…

Read more